Results 211 to 220 of about 839,584 (361)

Artificial Intelligence in Medicine: A Specialty-Level Overview of Emerging AI Trends. [PDF]

JSLS
Popover JL, Wallace SP, Feldman J, Chastain G, Kalathia C, Imam A, Almasri M, Toomey PG.   +7 more
europepmc   +1 more source

Characterizing epithelial‐mesenchymal transition‐linked heterogeneity in breast cancer circulating tumor cells at a single‐cell level

Molecular Oncology, EarlyView.
In over 50% of non‐metastatic breast cancer patients, circulating tumor cells (CTCs) along the whole epithelial‐mesenchymal transition spectrum are detected. Total CTC number and individual phenotypes relate to aggressive disease characteristics, including lymph node involvement and higher tumor proliferation. At the single‐cell level, mesenchymal CTCs
Justyna Topa, Julia Richert, Tomasz Stokowy, Alicja Staśczak, Mariusz Szajewski, Maciej Ciesielski, Petra M. Grešner, Bartłomiej Tomasik, Łukasz Arcimowicz, Agnieszka Stankiewicz, Grażyna Suchodolska, Elżbieta Senkus, Wiesław Kruszewski, Anna J. Żaczek, Aleksandra Markiewicz   +14 more
wiley   +1 more source

The Fusion of Robotics and Imaging: A Vision of the Future. [PDF]

Methodist Debakey Cardiovasc J
Quintero-Peña C, Shelton AR, Corr SJ, Lumsden AB.   +3 more
europepmc   +1 more source

The IFNγ‐CIITA‐MHC II axis modulates melanoma cell susceptibility to NK‐cell‐mediated cytotoxicity

Molecular Oncology, EarlyView.
Natural killer (NK) cells play a central role in anti‐melanoma immunity. However, melanoma cells adapt during co‐culture by upregulating CIITA and MHC II in response to interferon gamma (IFNγ), thereby evading NK‐cell lysis. Blocking IFNγ signaling or treatment with dimethyl fumarate/simvastatin counteracts this immune escape and maintains NK‐cell ...
Lena C. M. Krause, Rixa‐Mareike Köhn, Christian Ickes, Julia Lenger, Jonas Fischer, Sabrina Cappello, Ivan Bogeski   +6 more
wiley   +1 more source

Mapping the Evolution of Artificial Intelligence in Medical Materials. [PDF]

ACS Omega
Huang S, Jin Y, Hou X, Huang Z, Hu J, Yu H, He Z.   +6 more
europepmc   +1 more source

COMPUTATIONAL CHEMISTRY AND ITS APPLICATIONS IN MEDICINE: A REVIEW

International Research Journal Of Pharmacy, 2019
Shaimaa Hamed Jaber, Athraa S. Ahmed, Amel S. Mahdi, Kafi M. Dawood, Barakat A. F. Kamel   +4 more
openaire   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

Gastroenterology in the age of artificial intelligence: Bridging technology and clinical practice. [PDF]

World J Gastroenterol
Mehta Y, Mehta S, Bhayani V, Parikh S, Mehta R.   +4 more
europepmc   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

Current progress of digital twin construction using medical imaging. [PDF]

J Appl Clin Med Phys
Zhao F, Wu Y, Hu M, Chang CW, Liu R, Qiu R, Yang X.   +6 more
europepmc   +1 more source